199 related articles for article (PubMed ID: 10644065)
1. PAMAM dendrimers as delivery agents for antisense oligonucleotides.
Yoo H; Sazani P; Juliano RL
Pharm Res; 1999 Dec; 16(12):1799-804. PubMed ID: 10644065
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.
Yoo H; Juliano RL
Nucleic Acids Res; 2000 Nov; 28(21):4225-31. PubMed ID: 11058121
[TBL] [Abstract][Full Text] [Related]
3. Dendritic alpha,epsilon-poly(L-lysine)s as delivery agents for antisense oligonucleotides.
Eom KD; Park SM; Tran HD; Kim MS; Yu RN; Yoo H
Pharm Res; 2007 Aug; 24(8):1581-9. PubMed ID: 17373579
[TBL] [Abstract][Full Text] [Related]
4. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
Kang H; DeLong R; Fisher MH; Juliano RL
Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
[TBL] [Abstract][Full Text] [Related]
5. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.
Bielinska A; Kukowska-Latallo JF; Johnson J; Tomalia DA; Baker JR
Nucleic Acids Res; 1996 Jun; 24(11):2176-82. PubMed ID: 8668551
[TBL] [Abstract][Full Text] [Related]
6. Characterization of complexes of oligonucleotides with polyamidoamine starburst dendrimers and effects on intracellular delivery.
Delong R; Stephenson K; Loftus T; Fisher M; Alahari S; Nolting A; Juliano RL
J Pharm Sci; 1997 Jun; 86(6):762-4. PubMed ID: 9188063
[TBL] [Abstract][Full Text] [Related]
7. Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.
Márquez-Miranda V; Peñaloza JP; Araya-Durán I; Reyes R; Vidaurre S; Romero V; Fuentes J; Céric F; Velásquez L; González-Nilo FD; Otero C
Nanoscale Res Lett; 2016 Dec; 11(1):66. PubMed ID: 26847692
[TBL] [Abstract][Full Text] [Related]
8. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
Juliano RL
Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
[TBL] [Abstract][Full Text] [Related]
9. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
10. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost.
Liu H; Wang H; Yang W; Cheng Y
J Am Chem Soc; 2012 Oct; 134(42):17680-7. PubMed ID: 23050493
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.
Hollins AJ; Benboubetra M; Omidi Y; Zinselmeyer BH; Schatzlein AG; Uchegbu IF; Akhtar S
Pharm Res; 2004 Mar; 21(3):458-66. PubMed ID: 15070097
[TBL] [Abstract][Full Text] [Related]
12. Dendrimer-Enabled Therapeutic Antisense Delivery Systems as Innovation in Medicine.
Mignani S; Shi X; Zablocka M; Majoral JP
Bioconjug Chem; 2019 Jul; 30(7):1938-1950. PubMed ID: 31246431
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.
Kang SH; Cho MJ; Kole R
Biochemistry; 1998 May; 37(18):6235-9. PubMed ID: 9572837
[TBL] [Abstract][Full Text] [Related]
14. [Polyamidoamine dendrimer-mediated survivin antisense oligonucleotide inhibits the growth of subcutaneously transplanted colorectal cancer in nude mice].
Li Z; Huang ZH; Cui DX; Yao H; Yu JL; Li Q; Pan BF; Gao F
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):1935-8. PubMed ID: 19033096
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo.
Kang C; Yuan X; Li F; Pu P; Yu S; Shen C; Zhang Z; Zhang Y
J Biomed Mater Res A; 2010 May; 93(2):585-94. PubMed ID: 19591231
[TBL] [Abstract][Full Text] [Related]
16. Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.
Kang SH; Zirbes EL; Kole R
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):497-505. PubMed ID: 10645775
[TBL] [Abstract][Full Text] [Related]
17. The influence of surface modification on the cytotoxicity of PAMAM dendrimers.
Jevprasesphant R; Penny J; Jalal R; Attwood D; McKeown NB; D'Emanuele A
Int J Pharm; 2003 Feb; 252(1-2):263-6. PubMed ID: 12550802
[TBL] [Abstract][Full Text] [Related]
18. Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes.
Pedziwiatr-Werbicka E; Shcharbin D; Maly J; Maly M; Zaborski M; Gabara B; Ortega P; de la Mata FJ; Gómez R; Muñoz-Fernandez MA; Klajnert B; Bryszewska M
J Biomed Nanotechnol; 2012 Feb; 8(1):57-73. PubMed ID: 22515094
[TBL] [Abstract][Full Text] [Related]
19. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
[TBL] [Abstract][Full Text] [Related]
20. Polyamidoamine dendrimer liposome-mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis.
Han S; Cai Z; Peng L; Li Z; Zhou HB; Li XQ; Fang SZ; Huang ZH; Cui DX
Tumour Biol; 2014 May; 35(5):5013-9. PubMed ID: 24488668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
